GLOPID-R

DHSC, through the NIHR & UKRI – UK

Research to understand the disease, prevent, treat and control it will be critical for mitigating the severity of the 2019-nCoV outbreak.

Rapid progress in addressing this epidemic will depend upon a coherent and integrated response from researchers, industry, the healthcare system and the public. Consequently, a strategic call encompassing two different elements is being launched:

  • Active intervention development including vaccines and therapeutics, and
  • Diagnosis and understanding of 2019-nCoV.

Up to £20m will be made available for this initiative through the primary government funders of UK medical research – the Department of Health and Social Care, through the National Institute for Health Research, and UK Research and Innovation. This amount is expected to fund several awards in both calls.

Scope

Short term (up to 18 month) proposals are sought. All proposals will need to be able to show how progress within the period of award could make a significant contribution to the understanding, diagnosis, prevention and/or management of the 2019-nCoV outbreak.

Full request for proposal

  • Call budget: £20M
  • Call opens: February 4, 2020
  • Application deadlines:
    February 13, 2020 – Active intervention development including vaccines and therapeutics
    February 27, 2020 – Diagnosis and understanding of 2019-nCoV
EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.